載入...
Response to Lapatinib-Capecitabine combination in a young patient with recurrent HER2-positive breast cancer refractory to two lines of therapy with anti-HER2 drugs
HER2-positive breast cancer is an aggressive tumour that affects approximately one in five breast cancer women. Clinical studies have shown that HER2-positive cancer have different characteristics from other mammary tumors: a more rapid progression of the disease, an earlier age of onset (women of c...
Na minha lista:
| Main Authors: | , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
AboutScience Srl
2018-10-01
|
| 叢編: | AboutOpen |
| 主題: | |
| 在線閱讀: | https://journals.aboutscience.eu/index.php/aboutopen/article/view/135 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|